Nuevos anticoagulantes orales: ¿Qué Dicen Las Guías?
Background: Traditional oral anticoagulants, primarily warfarin, have occupied a central place in the prevention and treatment of thromboembolic diseases since their development in the 1940s.
Sossa Pinzón, Luis Alfredo +6 more
core
[Perception of physicians on factors that influence the choice of a dicoumarin or a new oral anticoagulant in patients with non-valvular atrial fibrillation]. [PDF]
Anguita-Sánchez M +7 more
europepmc +1 more source
Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studies. [PDF]
Anguita M +3 more
europepmc +1 more source
[The family doctor and the barriers to prescribing the new oral anticoagulants: Heterogeneity, inequality and confusion. Statement of the Spanish Primary Care and Family Medicine Societies]. [PDF]
Lobos Bejarano JM +2 more
europepmc +1 more source
[Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain]. [PDF]
Escolar-Albaladejo G +7 more
europepmc +1 more source
[Nurse prescription: A concept analysis]. [PDF]
Fernández Molero S +5 more
europepmc +1 more source

